Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
E K Rowinsky, M J Citardi, D A Noe, et al.
Journal of the National Cancer Institute
|
February 17, 1993
The current status of camptothecin analogues as antitumor agents
W J Slichenmyer, E K Rowinsky, R C Donehower, et al.
Cancer Research
|
November 1, 1984
Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism
J E Karp, R C Donehower, G B Dole, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics
L B Grochow, D A Noe, D S Ettinger, et al.
Cancer Research
|
February 1, 1990
Development of polyploidization in taxol-resistant human leukemia cells in vitro
J R Roberts, D C Allison, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of flavopiridol in patients with advanced colorectal cancer
M Aklilu, H L Kindler, R C Donehower, et al.
Cancer Surveys
|
January 1, 1993
Taxol: pharmacology, metabolism and clinical implications
E K Rowinsky, M Wright, B Monsarrat, et al.
Anti-Cancer Drugs
|
June 1, 1996
A phase II trial of topotecan in patients with previously untreated pancreatic cancer
S O'Reilly, R C Donehower, E K Rowinsky, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection
C Erlichman, R C Donehower, J L Speyer, et al.
Seminars in Oncology
|
August 1, 1993
Clinical toxicities encountered with paclitaxel (Taxol)
E K Rowinsky, E A Eisenhauer, V Chaudhry, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
E K Rowinsky, M J Citardi, D A Noe, et al.
Journal of the National Cancer Institute
|
February 17, 1993
The current status of camptothecin analogues as antitumor agents
W J Slichenmyer, E K Rowinsky, R C Donehower, et al.
Cancer Research
|
November 1, 1984
Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism
J E Karp, R C Donehower, G B Dole, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics
L B Grochow, D A Noe, D S Ettinger, et al.
Cancer Research
|
February 1, 1990
Development of polyploidization in taxol-resistant human leukemia cells in vitro
J R Roberts, D C Allison, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of flavopiridol in patients with advanced colorectal cancer
M Aklilu, H L Kindler, R C Donehower, et al.
Cancer Surveys
|
January 1, 1993
Taxol: pharmacology, metabolism and clinical implications
E K Rowinsky, M Wright, B Monsarrat, et al.
Anti-Cancer Drugs
|
June 1, 1996
A phase II trial of topotecan in patients with previously untreated pancreatic cancer
S O'Reilly, R C Donehower, E K Rowinsky, et al.
Journal of the National Cancer Institute
|
February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection
C Erlichman, R C Donehower, J L Speyer, et al.
Seminars in Oncology
|
August 1, 1993
Clinical toxicities encountered with paclitaxel (Taxol)
E K Rowinsky, E A Eisenhauer, V Chaudhry, et al.
Page
of 13